Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Docosahexaenoic and eicosapentaenoic acid supplementation does not exacerbate oxidative stress or intravascular haemolysis in homozygous sickle cell patients.

Daak AA, Ghebremeskel K, Mariniello K, Attallah B, Clough P, Elbashir MI.

Prostaglandins Leukot Essent Fatty Acids. 2013 Oct;89(5):305-11. doi: 10.1016/j.plefa.2013.09.006. Epub 2013 Sep 18.

PMID:
24095588
[PubMed - indexed for MEDLINE]
2.

Patients with sickle cell disease have reduced blood antioxidant protection.

Ren H, Ghebremeskel K, Okpala I, Lee A, Ibegbulam O, Crawford M.

Int J Vitam Nutr Res. 2008 May;78(3):139-47. doi: 10.1024/0300-9831.78.3.139.

PMID:
19003736
[PubMed - indexed for MEDLINE]
3.

Protective effect of the omega-3 polyunsaturated fatty acids: Eicosapentaenoic acid/Docosahexaenoic acid 1:1 ratio on cardiovascular disease risk markers in rats.

Lluís L, Taltavull N, Muñoz-Cortés M, Sánchez-Martos V, Romeu M, Giralt M, Molinar-Toribio E, Torres JL, Pérez-Jiménez J, Pazos M, Méndez L, Gallardo JM, Medina I, Nogués MR.

Lipids Health Dis. 2013 Oct 1;12:140. doi: 10.1186/1476-511X-12-140.

PMID:
24083393
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.

Thies F, Nebe-von-Caron G, Powell JR, Yaqoob P, Newsholme EA, Calder PC.

Am J Clin Nutr. 2001 Mar;73(3):539-48.

PMID:
11237929
[PubMed - indexed for MEDLINE]
Free Article
5.

Pilot study of omega-3 fatty acid supplements in sickle cell disease.

Okpala I, Ibegbulam O, Duru A, Ocheni S, Emodi I, Ikefuna A, Umar G, Asinobi I, Madu A, Okoye A, Nwagha T, Oguonu U, Uamai I, Agwu O, Nonyelu C, Anike U, Agu K, Anigbo C, Chukwura A, Ugwu O, Herrada S.

APMIS. 2011 Jul;119(7):442-8. doi: 10.1111/j.1600-0463.2011.02751.x. Epub 2011 Apr 17.

PMID:
21635551
[PubMed - indexed for MEDLINE]
6.

Allergic disease in infants up to 2 years of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation in pregnancy and lactation.

Furuhjelm C, Warstedt K, Fagerås M, Fälth-Magnusson K, Larsson J, Fredriksson M, Duchén K.

Pediatr Allergy Immunol. 2011 Aug;22(5):505-14. doi: 10.1111/j.1399-3038.2010.01096.x. Epub 2011 Feb 20.

PMID:
21332799
[PubMed - indexed for MEDLINE]
7.

Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).

Ren H, Ghebremeskel K, Okpala I, Ugochukwu CC, Crawford M, Ibegbulam O.

Prostaglandins Leukot Essent Fatty Acids. 2006 Jan;74(1):1-6. Epub 2005 Nov 28.

PMID:
16314081
[PubMed - indexed for MEDLINE]
8.

Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects.

Remans PH, Sont JK, Wagenaar LW, Wouters-Wesseling W, Zuijderduin WM, Jongma A, Breedveld FC, Van Laar JM.

Eur J Clin Nutr. 2004 Jun;58(6):839-45.

PMID:
15164103
[PubMed - indexed for MEDLINE]
9.

Effect of 6 Weeks of n-3 fatty-acid supplementation on oxidative stress in Judo athletes.

Filaire E, Massart A, Portier H, Rouveix M, Rosado F, Bage AS, Gobert M, Durand D.

Int J Sport Nutr Exerc Metab. 2010 Dec;20(6):496-506.

PMID:
21116022
[PubMed - indexed for MEDLINE]
10.
11.

A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement.

Rodrigo R, Korantzopoulos P, Cereceda M, Asenjo R, Zamorano J, Villalabeitia E, Baeza C, Aguayo R, Castillo R, Carrasco R, Gormaz JG.

J Am Coll Cardiol. 2013 Oct 15;62(16):1457-65. doi: 10.1016/j.jacc.2013.07.014. Epub 2013 Jul 31.

PMID:
23916928
[PubMed - indexed for MEDLINE]
Free Article
12.

The impact of supplemental n-3 long chain polyunsaturated fatty acids and dietary antioxidants on physical performance in postmenopausal women.

Hutchins-Wiese HL, Kleppinger A, Annis K, Liva E, Lammi-Keefe CJ, Durham HA, Kenny AM.

J Nutr Health Aging. 2013 Jan;17(1):76-80. doi: 10.1007/s12603-012-0415-3.

PMID:
23299384
[PubMed - indexed for MEDLINE]
13.

Effect of omega-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial.

Hamazaki K, Itomura M, Huan M, Nishizawa H, Sawazaki S, Tanouchi M, Watanabe S, Hamazaki T, Terasawa K, Yazawa K.

Nutrition. 2005 Jun;21(6):705-10.

PMID:
15925295
[PubMed - indexed for MEDLINE]
14.

Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial.

Daak AA, Ghebremeskel K, Hassan Z, Attallah B, Azan HH, Elbashir MI, Crawford M.

Am J Clin Nutr. 2013 Jan;97(1):37-44. doi: 10.3945/ajcn.112.036319. Epub 2012 Nov 28.

PMID:
23193009
[PubMed - indexed for MEDLINE]
Free Article
15.
16.

Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa.

Wheaton DH, Hoffman DR, Locke KG, Watkins RB, Birch DG.

Arch Ophthalmol. 2003 Sep;121(9):1269-78.

PMID:
12963609
[PubMed - indexed for MEDLINE]
17.

Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects.

Henderson WR Jr, Astley SJ, McCready MM, Kushmerick P, Casey S, Becker JW, Ramsey BW.

J Pediatr. 1994 Mar;124(3):400-8.

PMID:
8120709
[PubMed - indexed for MEDLINE]
18.

Dietary supplements for preventing postnatal depression.

Miller BJ, Murray L, Beckmann MM, Kent T, Macfarlane B.

Cochrane Database Syst Rev. 2013 Oct 24;10:CD009104. doi: 10.1002/14651858.CD009104.pub2. Review.

PMID:
24158923
[PubMed - indexed for MEDLINE]
19.

Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.

Freund Levi Y, Vedin I, Cederholm T, Basun H, Faxén Irving G, Eriksdotter M, Hjorth E, Schultzberg M, Vessby B, Wahlund LO, Salem N Jr, Palmblad J.

J Intern Med. 2014 Apr;275(4):428-36. doi: 10.1111/joim.12166. Epub 2014 Jan 11.

PMID:
24410954
[PubMed - indexed for MEDLINE]
20.

Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the Nutritional AMD Treatment 2 study.

Souied EH, Delcourt C, Querques G, Bassols A, Merle B, Zourdani A, Smith T, Benlian P; Nutritional AMD Treatment 2 Study Group.

Ophthalmology. 2013 Aug;120(8):1619-31. doi: 10.1016/j.ophtha.2013.01.005. Epub 2013 Feb 8.

PMID:
23395546
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk